Search

The article discusses the factors affecting efficacy of dapoxetinetreatment in Chinese patients with premature ejaculation (PE). Topics discussed include dapoxetine hydrochloride acting as a selective serotonin re-uptake inhibitor (SSRI) and being the first drug approved in China, evaluating the effect of treatment with dapoxetine 30 mg on-demand on Chinese patients with PE, significant improvements with dapoxetine treatment at week, and trial reported in European and the Asian-Pacific trials.

The article presents an abstract on the use of the intravaginal ejaculatory latency time (IELT) for the assessment of premature ejaculation (PE) in diagnosis, and in clinical trials for PE.

An abstract for the article "Self-Reported Intromission Times: A Potential New Tool for PE Evaluation in Chinese Men" is presented.

An abstract of the article "Clinical characteristics and desired treatment outcomes of Chinese men with premature ejaculation" by Z. Zhang and colleagues is presented.

An abstract of the study "Self-reported intromission times: a potential new tool for PE evaluation in Chinese men," by F. Yafi and colleagues, is presented.

An abstract of the article "Acceptance and Discontinuation Rates of Dapoxetine Treatment in Chinese Patients With Premature Ejaculation" by Z. Zhang et al. is presented.

An abstract of the article "Possible factors affecting efficacy of dapoxetine 30mg treatment in Chinese patients with premature ejaculation" is presented.